These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
451 related items for PubMed ID: 17689034
1. Boron neutron capture therapy in the treatment of locally recurred head and neck cancer. Kankaanranta L, Seppälä T, Koivunoro H, Saarilahti K, Atula T, Collan J, Salli E, Kortesniemi M, Uusi-Simola J, Mäkitie A, Seppänen M, Minn H, Kotiluoto P, Auterinen I, Savolainen S, Kouri M, Joensuu H. Int J Radiat Oncol Biol Phys; 2007 Oct 01; 69(2):475-82. PubMed ID: 17689034 [Abstract] [Full Text] [Related]
3. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA). Henriksson R, Capala J, Michanek A, Lindahl SA, Salford LG, Franzén L, Blomquist E, Westlin JE, Bergenheim AT, Swedish Brain Tumour Study Group. Radiother Oncol; 2008 Aug 01; 88(2):183-91. PubMed ID: 18336940 [Abstract] [Full Text] [Related]
7. Boron neuron capture therapy using epithermal neutrons for recurrent cancer in the oral cavity and cervical lymph node metastasis. Ariyoshi Y, Miyatake S, Kimura Y, Shimahara T, Kawabata S, Nagata K, Suzuki M, Maruhashi A, Ono K, Shimahara M. Oncol Rep; 2007 Oct 01; 18(4):861-6. PubMed ID: 17786347 [Abstract] [Full Text] [Related]
10. Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients. Kawabata S, Miyatake S, Nonoguchi N, Hiramatsu R, Iida K, Miyata S, Yokoyama K, Doi A, Kuroda Y, Kuroiwa T, Michiue H, Kumada H, Kirihata M, Imahori Y, Maruhashi A, Sakurai Y, Suzuki M, Masunaga S, Ono K. Appl Radiat Isot; 2009 Jul 01; 67(7-8 Suppl):S15-8. PubMed ID: 19398348 [Abstract] [Full Text] [Related]
11. Boron neutron capture therapy (BNCT) inhibits tumor development from precancerous tissue: an experimental study that supports a potential new application of BNCT. Monti Hughes A, Heber EM, Pozzi E, Nigg DW, Calzetta O, Blaumann H, Longhino J, Nievas SI, Aromando RF, Itoiz ME, Trivillin VA, Schwint AE. Appl Radiat Isot; 2009 Jul 01; 67(7-8 Suppl):S313-7. PubMed ID: 19376711 [Abstract] [Full Text] [Related]
12. Effectiveness of BNCT for recurrent head and neck malignancies. Kato I, Ono K, Sakurai Y, Ohmae M, Maruhashi A, Imahori Y, Kirihata M, Nakazawa M, Yura Y. Appl Radiat Isot; 2004 Nov 01; 61(5):1069-73. PubMed ID: 15308194 [Abstract] [Full Text] [Related]
13. L-boronophenylalanine-mediated boron neutron capture therapy for malignant glioma progressing after external beam radiation therapy: a Phase I study. Kankaanranta L, Seppälä T, Koivunoro H, Välimäki P, Beule A, Collan J, Kortesniemi M, Uusi-Simola J, Kotiluoto P, Auterinen I, Serèn T, Paetau A, Saarilahti K, Savolainen S, Joensuu H. Int J Radiat Oncol Biol Phys; 2011 Jun 01; 80(2):369-76. PubMed ID: 21236605 [Abstract] [Full Text] [Related]
17. Planned fractionated boron neutron capture therapy using epithermal neutrons for a patient with recurrent squamous cell carcinoma in the temporal bone: a case report. Haginomori S, Miyatake S, Inui T, Araki M, Kawabata S, Takamaki A, Lee K, Takenaka H, Kuroiwa T, Uesugi Y, Kumada H, Ono K. Head Neck; 2009 Mar 01; 31(3):412-8. PubMed ID: 18767175 [Abstract] [Full Text] [Related]
18. Preliminary treatment planning and dosimetry for a clinical trial of neutron capture therapy using a fission converter epithermal neutron beam. Kiger WS, Lu XQ, Harling OK, Riley KJ, Binns PJ, Kaplan J, Patel H, Zamenhof RG, Shibata Y, Kaplan ID, Busse PM, Palmer MR. Appl Radiat Isot; 2004 Nov 01; 61(5):1075-81. PubMed ID: 15308195 [Abstract] [Full Text] [Related]
19. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer. Biagioli MC, Harvey M, Roman E, Raez LE, Wolfson AH, Mutyala S, Han HS, Markoe A. Int J Radiat Oncol Biol Phys; 2007 Nov 15; 69(4):1067-73. PubMed ID: 17967302 [Abstract] [Full Text] [Related]
20. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer. Haddad R, Sonis S, Posner M, Wirth L, Costello R, Braschayko P, Allen A, Mahadevan A, Flynn J, Burke E, Li Y, Tishler RB. Cancer; 2009 Oct 01; 115(19):4514-23. PubMed ID: 19634161 [Abstract] [Full Text] [Related] Page: [Next] [New Search]